Spirohydantoin inhibitors of aldose reductase inhibit iron- and copper-catalysed ascorbate oxidation in vitro
- 22 August 1991
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 42 (6) , 1273-1278
- https://doi.org/10.1016/0006-2952(91)90265-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Protein glycation and oxidative stress in diabetes mellitus and ageingFree Radical Biology & Medicine, 1991
- Is glucose the sole source of tissue browning in diabetes mellitus?FEBS Letters, 1990
- PREVALENCE OF GENETIC HAEMOCHROMATOSIS AMONG DIABETIC PATIENTSThe Lancet, 1989
- Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageingBiochemical Journal, 1988
- Glucose autoxidation and protein modification. The potential role of ‘autoxidative glycosylation’ in diabetesBiochemical Journal, 1987
- The behaviour of caeruloplasmin in stored human extracellular fluids in relation to ferroxidase II activity, lipid peroxidation and phenanthroline-detectable copperBiochemical Journal, 1985
- Determination of copper concentration in blood plasma and in ocular and cerebrospinal fluids using graphite furnace atomic absorption spectroscopyAnalytical Biochemistry, 1983
- Iron Overload Disorders: Natural History, Pathogenesis, Diagnosis, and TherapyCRC Critical Reviews in Clinical Laboratory Sciences, 1983
- The interaction of copper(II) and glycyl-l-histidyl-l-lysine, a growth-modulating tripeptide from plasmaBiochemical Journal, 1981
- Scurvy and Altered Iron Stores in Thalassemia MajorNew England Journal of Medicine, 1981